QTI$2.22+3.26%
Qt Imaging Holdings, Inc.
Sector: Electromedical & Electrotherapeutic ApparatusIndustry: Medical - DevicesCountry: USExchange: Nasdaq
Mkt Cap:$32.49M
Float & O/S:
Inst Own:
DilutionScan read 20 of QT IMAGING HOLDINGS, INC.'s SEC filings and found 14 warrant series, 3 convertibles, 1 equity line, 1 shelf registration, 2 S-1 registrations and 3 completed offerings on file for QTI. The latest dilution event on file is an offering on May 18, 2026. Analysis updated Oct 7, 2026.
Signal8 Summary
QTI
Growing revenue but burning cash fast
Snapshot
QT Imaging is a tiny medical-device maker whose sales are ramping fast: FY 2025 revenue hit $18.9M, up 288%, and it recently guided to $39M for FY 2026.
What's Happening Right Now
- : Q2 2026 revenue rose 103% to $7.4M on scanner shipments, but net loss widened to $11.1M, driven mostly by an $8.3M non-cash charge from modifying its term loan, which pushed the maturity to March 2029 at a higher 12% rate.
- : Gross margin slipped to 41% from 50%, quarterly cash burn tripled to $4.8M, and the company raised $10M in a public offering while cash and restricted cash stood at $14.2M as of August 7, 2026.
- : The Israeli Ministry of Health registered the company's scanner, authorizing commercialization in Israel through February 2028.
- : QT Imaging passed its first routine FDA inspection with zero Form 483 observations, a clean result for its quality system.
- : The company completed a 3:1 reverse stock split and an $18.2M private placement in October 2025 ahead of its January 2026 Nasdaq uplisting.
